Page results
-
To mark International Brain Tumour Awareness Week, UCLH and The National Brain Appeal are announcing a new clinical trial for patients with recurrent glioblastoma brain cancer.
-
This page describes a surgical keyhole procedure to remove fibroids, called a laparoscopic myomectomy.
-
Pfizer Limited, in agreement with the Medicines Healthcare products Regulatory Agency (MHRA), has withdrawn the product, while a review of the benefits and risks is carried out.
-
The function to book blood test appointments will soon be transferred from MyCare to Swiftqueue. Target go-live date: 27th June
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
A team of clinician scientists at UCLH have identified the factors which predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.
-
The British Medical Association (BMA) has announced that its junior doctor members will take industrial action between 13 and 16 March. The strike action will impact all UCLH hospitals.
-
Advice on preventing the spread of flu and other respiratory viruses, to keep UCLH patients safe.
-
EMIS outage caused backlog of result messages via Keystone
-
The British Medical Association (BMA) has announced that its junior doctor members will take industrial action between 11 and 15 April. The strike action will impact all UCLH hospitals.
File results
-
Council of Governors meeting papers - 31 October
-
Consultant - to -consultant referral form
-
UCLH Provider to Provider Tariff 2019-20
-
What young people would like everyone to know about Type 1 Diabetes
-
Reverse mentoring
-
FOI/2020/0572 - Inflamatory bowel disease staff contact details
-
FOI2017294 Contactors and subcontractors working on the Phase 4 and proton therapy beam
-
FOI/2020/0589 - Senior staff contacts for CEO, Director of Innovation and Chief Pharmacist
-
FOI/2020/0630 - CEO, Operations Director and Health and Safety Director contact details
-
FOI2017333 Midwifery contacts for accessing return to practice placements